MiR-34a is Involved in the Decrease of ATP Contents Induced by Resistin Through Target on ATP5S in HepG2 Cells

被引:20
作者
Wen, Fengyun [1 ]
Li, Bin [2 ]
Huang, Chunyan [2 ]
Wei, Zhiguo [1 ]
Zhou, Yingying [1 ]
Liu, Jianyu [1 ]
Zhang, Haiwei [1 ]
机构
[1] Henan Univ Sci & Technol, Coll Anim Sci & Technol, Luoyang 471003, Henan, Peoples R China
[2] Huazhong Agr Univ, Coll Life Sci & Technol, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan 430070, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
miR-34a; ATP contents; Resistin; ATP5S; CARDIOVASCULAR-DISEASE; ADIPOSE-TISSUE; EXPRESSION; MICRORNA; OBESITY; ADIPONECTIN; GENES;
D O I
10.1007/s10528-015-9693-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Resistin is associated with metabolic syndrome and deciphering its developmental and molecular mechanisms may help the development of new treatments. MiRNAs serve as negative regulators in many physiological and pathological processes. Here, miRNA microarrays were used to detect differences in expression between resistin-treated and control mice, and results showed miR-34a to be upregulated by resistin. The purpose of this study was to determine whether miR-34a played a role in resistin-induced decrease of ATP contents. Transient transfection of miR-34a mimics was used to overexpress miR-34a and quantitative RT-PCR was used to detect its expression. Western blot analysis was used to determine the rate of expression at the protein level. ATP content was measured using an ATP assay kit. The target gene of miR-34a was analyzed using bioinformatics and confirmed with dual-luciferase report system. MiR-34a was upregulated by resistin in HepG2 cells, and overexpression of miR-34a was found to diminish ATP levels significantly. This study is the first to show that ATP5S is one of the target genes of miR-34a. Resistin diminishes ATP content through the targeting of ATP5S mRNA 3'UTR by miR-34a.
引用
收藏
页码:301 / 309
页数:9
相关论文
共 29 条
[1]
Abate N, 2014, CURR PHARM DESIGN, V20, P4961, DOI 10.2174/1381612819666131206103102
[2]
Regulation of fasted blood glucose by resistin [J].
Banerjee, RR ;
Rangwala, SM ;
Shapiro, JS ;
Rich, AS ;
Rhoades, B ;
Qi, Y ;
Wang, J ;
Rajala, MW ;
Pocai, A ;
Scherer, PE ;
Steppan, CM ;
Ahima, RS ;
Obici, S ;
Rossetti, L ;
Lazar, MA .
SCIENCE, 2004, 303 (5661) :1195-1198
[3]
MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[4]
MicroRNA regulation and interspecific variation of gene expression [J].
Cui, Qinghua ;
Yu, Zhenbao ;
Purisima, Enrico O. ;
Wang, Edwin .
TRENDS IN GENETICS, 2007, 23 (08) :372-375
[5]
MicroRNA Control of Vascular Endothelial Growth Factor Signaling Output During Vascular Development [J].
Dang, Lan T. H. ;
Lawson, Nathan D. ;
Fish, Jason E. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (02) :193-200
[6]
Resistin expression correlates with steatohepatitis in morbidly obese patients [J].
Edwards, Claire R. ;
Hindle, A. Katharine ;
Latham, Patricia S. ;
Fu, Sidney W. ;
Brody, Fred J. .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2013, 27 (04) :1310-1314
[7]
Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function [J].
Fargnoli, Jessica L. ;
Sun, Qi ;
Olenczuk, Deanna ;
Qi, Lu ;
Zhu, Ying ;
Hu, Frank B. ;
Mantzoros, Christos S. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 162 (02) :281-288
[8]
Clinical characteristics and associated comorbidities in diabetic patients with cranial nerve palsies [J].
Greco, D. ;
Gambina, F. ;
Pisciotta, M. ;
Abrignani, M. ;
Maggio, F. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (02) :146-149
[9]
THE EXPRESSION OF SUBUNIT-C CORRELATES WITH AND THUS MAY LIMIT THE BIOSYNTHESIS OF THE MITOCHONDRIAL F0F1-ATPASE IN BROWN ADIPOSE-TISSUE [J].
HOUSTEK, J ;
ANDERSSON, U ;
TVRDIK, P ;
NEDERGAARD, J ;
CANNON, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) :7689-7694
[10]
Resistin: functional roles and therapeutic considerations for cardiovascular disease [J].
Jamaluddin, Md S. ;
Weakley, Sarah M. ;
Yao, Qizhi ;
Chen, Changyi .
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (03) :622-632